Ischemin, CBP Bromodomain Inhibitor
Overview | |
Catalog # | bs-60229c-2-mg-solid |
Product Name | Ischemin, CBP Bromodomain Inhibitor |
Specifications | |
Storage Buffer | Powder |
Storage Condition | Store in dry, dark place at -20C for 1 year. |
Target | |
Product Information | Molecular Weight: 357.36 Formula: C15 H16 N3 Na O4 S CAS Number: 1357059-00-7 InChi Key: ZTDQQIATQGCZBV-ZAGWXBKKSA-M InChi: InChI=1S/C15H17N3O4S.Na/c1-8-4-10(3)15(23(20,21)22)7-12(8)17-18-13-5-9(2)14(19)6-11(13)16;/h4-7,19H,16H2,1-3H3,(H,20,21,22);/q;+1/p-1/b18-17+; Smiles: [Na+].CC1C=C(C)C(=CC=1S([O-])(=O)=O)/N=N/C1C=C(C)C(O)=CC=1N Purity: 98.0 Solubility: DMSO up to 100 mM Appearance: Solid Power. Shelf Life: 1.0 years |
Description | Ischemin is a potent, selective and cell permeable CBP bromodomain inhibitor. It inhibits the acetyl-lysine binding activity of the bromodomain of CBP. It alters post-translational modifications on p53 and histones, inhibits p53 interaction with CBP and transcriptional activity in cells, and prevents Doxorubicin-induced apoptosis in ischemic cardiomyocytes. Ischemin is a good chemical probe to modulate acetylation-mediated interactions in gene transcription and a new approach to therapeutic interventions of human disorders such as myocardial ischemia |